Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors
- PMID:19596662
- DOI: 10.1093/jjco/hyp074
Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors
Abstract
The purpose of this study is to evaluate the improved method of arterial infusion therapy of SMANCS (SX) with lipiodol under the angiotensin-induced hypertensive state for various difficult-to-treat solid tumors. Most patients were unresectable with no other therapeutic options, recurrence after resection, or patients do not respond to common treatments. The new method utilizes angiotensin II (AT) to induce hypertension (e.g. approximately 15-30 mmHg above norm) for 15-20 min. This method was successfully applied to metastatic liver cancer, cholangiocarcinoma, massive renal cell carcinoma, pancreatic and other abdominal solid cancers. This AT-induced hypertension resulted in remarkably enhanced tumor delivery accompanied by improved therapeutic response, and a shorter time to achieve 50% regression of tumor size with least toxicity. We demonstrated clinically herein improved therapy for various advanced solid tumors with SX by elevating the tumor blood flow selectively. This is the first clinical proof that modulations of vascular pathophysiology can uniquely accomplish enhanced tumor selective delivery of polymeric drugs and thus yielded better clinical outcome.
Similar articles
- [Clinical experience of treatment of liver metastasis of renal cell carcinoma treated with SMANCS/Lipiodol therapy].Umeda S, Ito K, Takahashi E, Kimura F, Sumitomo M, Kaji T, Hayakawa M, Asano T.Umeda S, et al.Hinyokika Kiyo. 2010 Oct;56(10):543-9.Hinyokika Kiyo. 2010.PMID:21063157Japanese.
- [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.Takizawa K, et al.Gan To Kagaku Ryoho. 1998 Feb;25 Suppl 1:24-9.Gan To Kagaku Ryoho. 1998.PMID:9512683Japanese.
- [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].Jin-no K.Jin-no K.Gan To Kagaku Ryoho. 1998 Feb;25 Suppl 1:90-8.Gan To Kagaku Ryoho. 1998.PMID:9512695Japanese.
- [Arterial infusion chemotherapy with SMANCS].Nekohashi T, Maruno J, Sanjou A, Toda G.Nekohashi T, et al.Nihon Rinsho. 2001 Oct;59 Suppl 6:629-33.Nihon Rinsho. 2001.PMID:11762025Review.Japanese.No abstract available.
- [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].Konno T, Maeda H.Konno T, et al.Gan To Kagaku Ryoho. 1988 Apr;15(4 Pt 2-1):1043-50.Gan To Kagaku Ryoho. 1988.PMID:2839112Review.Japanese.
Cited by
- Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.Sukhatme V, Bouche G, Meheus L, Sukhatme VP, Pantziarka P.Sukhatme V, et al.Ecancermedicalscience. 2015 Aug 27;9:568. doi: 10.3332/ecancer.2015.568. eCollection 2015.Ecancermedicalscience. 2015.PMID:26435741Free PMC article.
- Be Active or Not: the Relative Contribution of Active and Passive Tumor Targeting of Nanomaterials.Li R, Zheng K, Yuan C, Chen Z, Huang M.Li R, et al.Nanotheranostics. 2017 Jul 11;1(4):346-357. doi: 10.7150/ntno.19380. eCollection 2017.Nanotheranostics. 2017.PMID:29071198Free PMC article.Review.
- Hybrid-Actuating Macrophage-Based Microrobots for Active Cancer Therapy.Han J, Zhen J, Du Nguyen V, Go G, Choi Y, Ko SY, Park JO, Park S.Han J, et al.Sci Rep. 2016 Jun 27;6:28717. doi: 10.1038/srep28717.Sci Rep. 2016.PMID:27346486Free PMC article.
- Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer?Nakamura Y, Mochida A, Choyke PL, Kobayashi H.Nakamura Y, et al.Bioconjug Chem. 2016 Oct 19;27(10):2225-2238. doi: 10.1021/acs.bioconjchem.6b00437. Epub 2016 Sep 2.Bioconjug Chem. 2016.PMID:27547843Free PMC article.Review.
- Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation.Toy R, Hayden E, Camann A, Berman Z, Vicente P, Tran E, Meyers J, Pansky J, Peiris PM, Wu H, Exner A, Wilson D, Ghaghada KB, Karathanasis E.Toy R, et al.ACS Nano. 2013 Apr 23;7(4):3118-29. doi: 10.1021/nn3053439. Epub 2013 Mar 14.ACS Nano. 2013.PMID:23464827Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical